Globe Life raises annual earnings forecast after reporting margin increase in Q2
GL•Outlook and valuation notes
-
Globe Life raises full-year 2026 earnings guidance to $15.55-$15.95 per share
-
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 11 "strong buy" or "buy", 4 "hold" and no "sell" or "strong sell"
-
The average consensus recommendation for the life & health insurance peer group is "hold"
-
Wall Street's median 12-month price target for Globe Life Inc is $192.50, about 4.4% above its July 21 closing price of $184.34
-
The stock recently traded at 11 times the next 12-month earnings vs. a P/E of 9 three months ago
Quarterly results and business drivers
-
U.S. life and health insurer's Q2 net income per share rose 20% yr/yr
-
Total premium revenue for Q2 grew 7% from a year earlier
-
Company repurchased 1.1 mln shares for $175 mln during the quarter
-
PREMIUM REVENUE GROWTH - Total premium revenue rose 7% yr/yr, with life premium up 3% and health premium up 16%
